Testing the Effectiveness of a Novel Intervention to Improve Medication Adherence in Stroke Survivors

Inclusion Criteria

• •1. Participants must be between the ages of 18 years old and 99 years old at the time of consent.
• •2. Self-reported primary diagnosis of stroke (ischemic or hemorrhagic) within the past 12 months, without structural, traumatic or secondary causes (including aneurysm, arteriovenous malformation, or tumor).
• •3. Currently prescribed an antihypertensive regimen.
• •4. Currently less than optimal adherence to medication, defined as a score \<25 on the Medication Adherence Report Scale (MARS-5).
• •5. Cognitively able to manage medications independently, defined as a score of \>4 on the Six-Item Screener (SIS) for cognitive impairment.
• •6. Speaks English sufficiently to complete consent and study procedures.
• •7. Has access to a phone that can receive text messages and is able to participate in scheduled phone-based follow-up assessments.
• •8. Uses, or willing to start using, a single pharmacy chain for prescription refills and is willing to provide consent for the study team to contact the pharmacy to retrieve prescription refill data.
• •9. Willing and able to provide informed consent.